Robert Vander Broek

578 total citations
8 papers, 469 citations indexed

About

Robert Vander Broek is a scholar working on Molecular Biology, Pulmonary and Respiratory Medicine and Cancer Research. According to data from OpenAlex, Robert Vander Broek has authored 8 papers receiving a total of 469 indexed citations (citations by other indexed papers that have themselves been cited), including 6 papers in Molecular Biology, 3 papers in Pulmonary and Respiratory Medicine and 3 papers in Cancer Research. Recurrent topics in Robert Vander Broek's work include Lung Cancer Treatments and Mutations (3 papers), PI3K/AKT/mTOR signaling in cancer (3 papers) and Cancer-related molecular mechanisms research (2 papers). Robert Vander Broek is often cited by papers focused on Lung Cancer Treatments and Mutations (3 papers), PI3K/AKT/mTOR signaling in cancer (3 papers) and Cancer-related molecular mechanisms research (2 papers). Robert Vander Broek collaborates with scholars based in United States and Germany. Robert Vander Broek's co-authors include Carter Van Waes, Suresh Mohan, Danielle F. Eytan, Z Chen, Zhong Chen, Keith L. Kirkwood, Nisha J. D’Silva, Gregory T. Wolf, Carol R. Bradford and Thomas E. Carey and has published in prestigious journals such as Cancer, Clinical Cancer Research and Molecular Cancer Therapeutics.

In The Last Decade

Robert Vander Broek

8 papers receiving 460 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Robert Vander Broek United States 8 334 163 145 83 41 8 469
Shu‐Chun Lin Taiwan 10 214 0.6× 135 0.8× 107 0.7× 41 0.5× 41 1.0× 23 380
Shi‐Juan Mai China 15 375 1.1× 133 0.8× 225 1.6× 64 0.8× 57 1.4× 32 572
Tatiana de Almeida Simão Brazil 14 316 0.9× 115 0.7× 108 0.7× 59 0.7× 35 0.9× 28 475
Reid Loveless United States 11 332 1.0× 85 0.5× 137 0.9× 94 1.1× 127 3.1× 14 507
Zumin Xu China 13 294 0.9× 109 0.7× 141 1.0× 47 0.6× 44 1.1× 24 427
Domenico Zito Italy 8 164 0.5× 117 0.7× 123 0.8× 51 0.6× 78 1.9× 12 427
Bok‐Soon Lee South Korea 11 204 0.6× 117 0.7× 72 0.5× 38 0.5× 64 1.6× 24 358
Aman Wang China 13 344 1.0× 162 1.0× 133 0.9× 73 0.9× 51 1.2× 21 449
Aïda Ghoul France 8 254 0.8× 85 0.5× 58 0.4× 33 0.4× 44 1.1× 10 379
Takahiro Shiraishi Japan 9 395 1.2× 200 1.2× 144 1.0× 71 0.9× 54 1.3× 45 595

Countries citing papers authored by Robert Vander Broek

Since Specialization
Citations

This map shows the geographic impact of Robert Vander Broek's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Robert Vander Broek with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Robert Vander Broek more than expected).

Fields of papers citing papers by Robert Vander Broek

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Robert Vander Broek. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Robert Vander Broek. The network helps show where Robert Vander Broek may publish in the future.

Co-authorship network of co-authors of Robert Vander Broek

This figure shows the co-authorship network connecting the top 25 collaborators of Robert Vander Broek. A scholar is included among the top collaborators of Robert Vander Broek based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Robert Vander Broek. Robert Vander Broek is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

8 of 8 papers shown
1.
Mohan, Suresh, Robert Vander Broek, Danielle F. Eytan, et al.. (2015). MEK Inhibitor PD-0325901 Overcomes Resistance to PI3K/mTOR Inhibitor PF-5212384 and Potentiates Antitumor Effects in Human Head and Neck Squamous Cell Carcinoma. Clinical Cancer Research. 21(17). 3946–3956. 54 indexed citations
2.
Banerjee, Rajat, Elizabeth A. Van Tubergen, Christina Springstead Scanlon, et al.. (2014). The G Protein–Coupled Receptor GALR2 Promotes Angiogenesis in Head and Neck Cancer. Molecular Cancer Therapeutics. 13(5). 1323–1333. 28 indexed citations
3.
Bian, Yansong, Robert Vander Broek, Bradford Hall, et al.. (2013). PI3K/mTOR Inhibitor PF-04691502 Antitumor Activity Is Enhanced with Induction of Wild-Type TP53 in Human Xenograft and Murine Knockout Models of Head and Neck Cancer. Clinical Cancer Research. 19(14). 3808–3819. 66 indexed citations
4.
Tubergen, Elizabeth A. Van, Rajat Banerjee, Min Liu, et al.. (2013). Inactivation or Loss of TTP Promotes Invasion in Head and Neck Cancer via Transcript Stabilization and Secretion of MMP9, MMP2, and IL-6. Clinical Cancer Research. 19(5). 1169–1179. 70 indexed citations
5.
Friedman, Jay, Michael Y. Hu, Robert Vander Broek, et al.. (2013). HSP90 Inhibitor SNX5422/ 2112 Targets the Dysregulated Signal and Transcription Factor Network and Malignant Phenotype of Head and Neck Squamous Cell Carcinoma. Translational Oncology. 6(4). 429–IN5. 21 indexed citations
6.
Broek, Robert Vander, et al.. (2013). Chemoprevention of head and neck squamous cell carcinoma through inhibition of NF-κB signaling. Oral Oncology. 50(10). 930–941. 42 indexed citations
7.
Broek, Robert Vander, Suresh Mohan, Danielle F. Eytan, Z Chen, & Carter Van Waes. (2013). The PI3K/Akt/mTOR axis in head and neck cancer: functions, aberrations, cross‐talk, and therapies. Oral Diseases. 21(7). 815–825. 129 indexed citations
8.
Broek, Robert Vander, Jungwha Lee, Gregory T. Wolf, et al.. (2011). Tristetraprolin regulates interleukin‐6, which is correlated with tumor progression in patients with head and neck squamous cell carcinoma. Cancer. 117(12). 2677–2689. 59 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Shu‐Chun Lin Breakdown of academic impact, for papers by Shi‐Juan Mai Breakdown of academic impact, for papers by Tatiana de Almeida Simão Breakdown of academic impact, for papers by Reid Loveless Breakdown of academic impact, for papers by Zumin Xu Breakdown of academic impact, for papers by Domenico Zito Breakdown of academic impact, for papers by Bok‐Soon Lee Breakdown of academic impact, for papers by Aman Wang Breakdown of academic impact, for papers by Aïda Ghoul Breakdown of academic impact, for papers by Takahiro Shiraishi
Rankless by CCL
2026